RPE65 and Leber congenital amaurosis: After efficacy was shown in a naturally occurring canine model, multiple clinical trials confirmed that an AAV vector delivering RPE65 was safe and improved visual function during the follow-up of LCA patients [4,5,6,7,29,31,32,33,40,116,117,118,119].